Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alexis Johnston
Institution:
Georgia Institute of Technology
Observed institution:
Georgia Institute of Technology
ORCID:
0000-0001-7598-2895
Observed ORCID:
0000-0001-7598-2895
OpenAlex ID:
A5042776295
Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC)
2023
·
Balaji Chandrasekaran
, Subhasish Tapadar
, et al.
·
Cancers
·
11
PDF
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy
2024
·
Bocheng Wu
, Subhasish Tapadar
, et al.
·
ACS Pharmacology & Translational Science
·
8
Gαi2 Protein Inhibition Blocks Chemotherapy- and Anti-Androgen-Induced Prostate Cancer Cell Migration
2024
·
Silvia Caggia
, Alexis Johnston
, et al.
·
Cancers
·
6
PDF
Repositioning Antihistamine for Cancer Therapy: Clemizole as a Template for the Design of Liver Tissue-Targeting Epigenetic-Modifying Agents
2026
·
Dipak T. Walunj
, Bocheng Wu
, et al.
·
Journal of Medicinal Chemistry
·
2
Transcriptomic Signature and PROTAC Strategy Revealed Histone Lysine Demethylase as a Target of Anticancer Activity of Deferiprone
2026
·
Alexis Johnston
, Jeremiah O. Olugbami
, et al.
·
ACS Omega
·
1
PDF
Dual-acting Estrogen Receptor Modulator-Histone Lysine Demethylase Inhibitors
2026
·
Dipak T. Walunj
, Jeremiah O. Olugbami
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 4492: Deferiprone optimization for the treatment of triple-negative breast cancer
2024
·
Alexis Johnston
, Adegboyega K. Oyelere
·
Cancer Research
Abstract 3092: Optimization of deferiprone for the treatment of triple-negative breast cancer
2023
·
Alexis Johnston
, Adegboyega K. Oyelere
·
Cancer Research
Show more works
View as search
Works count:
8
Citation count:
28
H-index:
3
I10-index:
1
Year
Topic
Type